U.S. FDA Expands Authorization of Pfizer Bivalent COVID-19 Shots in Kids (Reuters) - Pfizer Inc said on Tuesday that the U.S. Food and Drug Administration had expanded the emergency use ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least ...

In December 2022, the FDA authorized the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to be given as the third dose in the primary series for children in this age group, who already received the ...

Opens in a new tab or window More children under age 5 are now eligible for a COVID ... vaccine and a bivalent booster, FDA said. One month after the bivalent booster, these kids "demonstrated ...

A decision by the FDA on the updated bivalent booster shot is not yet final. This news comes a month after the Centers for ...

The FDA may make a second updated COVID-19 booster shot available this spring to older and medically vulnerable Americans.

bivalent COVID-19 vaccine as a single booster dose in certain children. The amended authorization is for children six months through four years of age who have completed their initial three-dose ...

Try the tool that will help you invest smarter, faster, and better. This article FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids originally appeared on Benzinga.com ...